[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![_Investor_Feed_ Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1825090112713285632.png) Investor Feed [@_Investor_Feed_](/creator/twitter/_Investor_Feed_) on x 6076 followers
Created: 2025-07-23 10:49:38 UTC

Natco Pharma Expands into South Africa with Major Stake Acquisition 🚀 | MCap XXXXXXXXX Cr

- Natco Pharma acquires XXXXX% stake in Adcock Ingram (South Africa) for ₹2000 crores (ZAR X billion).
- Purchase price: ZAR XXXXX per share (approx. US$4.27) for XXXXXXXXXX shares.
- Natco to set up a new subsidiary in South Africa with an investment up to ₹2100 crores.
- Adcock Ingram is a leading South African pharma firm with FY24 revenue of ZAR XXXXX million (US$536 million).
- Adcock’s FY24 financials: EBITDA of US$78 million, net profit of US$45 million.
- Post-acquisition, Natco will consolidate XXXXX% of Adcock’s net profits.
- Bidvest retains XXXXX% stake; Adcock remains a private South African business.
- Natco plans to liquidate subsidiary Time Cap Overseas Limited (TCOL) to directly hold investment in NatcoFarma do Brasil Ltda.
- Deal expected to close by December 31, 2025, pending regulatory approvals.
- Strategic goals: Expand geographic footprint, enhance R&D, and drive market growth.

Complete Source:

Disc: Information provided in this tweet can be inaccurate, verify through the source before making any investment decision.

Preview 👇 (First X out of X pages)

![](https://pbs.twimg.com/media/GwiWZVxaUAAmJuv.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947972368410005982/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[zar](/topic/zar)
[mcap](/topic/mcap)
[acquisition](/topic/acquisition)
[south africa](/topic/south-africa)
[investment](/topic/investment)

[Post Link](https://x.com/_Investor_Feed_/status/1947972368410005982)